Selective effect signal on liver cancer tissue in phase Ia study with MIV-818Read more
Medivir to present at the 2019 BIO International ConventionRead more
New data from the phase I study of birinapant in combination with Keytruda® presented at ASCORead more
Quarterly report presentations
Medivir Corporate Governance documention.
Documentation from Medivir's Annual General Meetings.